Showing posts with label congenital heart disease. Show all posts
Showing posts with label congenital heart disease. Show all posts

Friday, November 2, 2018

GE Healthcare new fetalHQ software streamlines evaluation of congenital heart diseases


The ultrasonologist can now assess the size, shape, and function of the fetal heart in less than 3 minutes with the GE Healthcare new fetalHQ software. Evaluating fetal heart and ruling out congenital heart anomalies is complicated at 18-20 weeks. This condition is not uncommon and affects one out of every 110 babies around the world.

At this gestational age, the fetal heart is exceptionally complex, just the size of a grape and the rate is near twice the adult heart rate. GE new tool – fetalHQ runs on GE Healthcare’s Voluson ultrasound systems and is the first tool to simultaneously examine the size, shape, and function of the fetal heart.

fetalHQ is the brainchild of Greggory DeVore, M.D., a specialist in maternal-fetal medicine at Huntington Hospital, Pasadena, California. He got inspired to develop the software from another software that used speckle tracking analysis to map the motion of tissues in the heart. This software was regularly used by adult and pediatric cardiologist to assess the function of the heart.

Dr. DeVore installed the software and reprogrammed it to visualize the fetal heart in 24 segments and map it in a way that was never done earlier.

“This was the genesis of the creativity behind using this software,” DeVore said. “From this, we made several measurements of the heart’s size, shape, and contractility – or how it’s squeezing. We immediately got to work and published 13 peer-reviewed articles that described the clinical value of this software.”

Here is a video showing the fetalHQ‘s automatic delineation of the fetal heart’s shape